|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-03
|
$138,333
|
$138,333
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Antigen Specific T Cell tolerance by Anti CD3 Antibodies
|
9R01CA132197-06A2
|
$361,592
|
$361,592
|
ANASETTI, CLAUDIO
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Host-Tumor Cell Interactions in Myeloma:
|
3P01CA078378-10S1
|
$1,346,410
|
$444,315
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
THE THERAPY OF AML
|
5P01CA055164-16
|
$2,374,635
|
$593,659
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adult Leukemia Research Center
|
3P01CA018029-33S1
|
$140,652
|
$140,652
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-33
|
$4,943,916
|
$4,943,916
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-24
|
$683,939
|
$683,939
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-03
|
$420,766
|
$420,766
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-14
|
$3,532,781
|
$635,901
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$349,253
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-10
|
$537,840
|
$268,920
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$94,815
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cytotoxic-T-Lymphocyte (CTL) Therapy of AML
|
5R01CA072669-12
|
$298,185
|
$298,185
|
Blazar, Bruce
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Marrow Infiltrating Lymphocyte Immunotherapy in Myeloma
|
1R21CA130344-01A2
|
$369,000
|
$369,000
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-02
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
|
1R21CA123855-01A2
|
$391,915
|
$391,915
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Hematopoietic Lineage-restricted Minor Histocompatibility Antigens as GVL Targets
|
5R01CA118880-02
|
$235,181
|
$235,181
|
BRICKNER, ANTHONY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support Grant
|
3P30CA046934-21S1
|
$728,250
|
$29,130
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-21S2
|
$73,150
|
$2,926
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
3P30CA046934-21S3
|
$85,992
|
$3,440
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
Cancer Center Support Grant
|
5P30CA046934-21
|
$3,604,774
|
$144,191
|
BUNN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$233,615
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Surgical Oncology Research Training
|
5T32CA106493-04
|
$110,928
|
$27,732
|
Cance, William
|
UNIVERSITY OF FLORIDA
|
|
Cancer Center Support Grant
|
2P30CA016087-28
|
$2,640,338
|
$26,403
|
CARROLL, WILLIAM
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$5,794
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$12,360
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$4,635
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$3,824
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$200,283
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia
|
5K08CA120544-03
|
$133,272
|
$33,318
|
CHIANG, MARK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Hematopoietic Stem Cell Donor Enrollment and Retention in Korean Americans
|
5R03CA130726-02
|
$63,000
|
$63,000
|
CHOE, JOHN
|
UNIVERSITY OF WASHINGTON
|
|
Hematopoietic Stem Cells for Transplantation
|
2P01CA070970-10A1
|
$2,035,680
|
$468,206
|
CIVIN, CURT
|
JOHNS HOPKINS UNIVERSITY
|
|
Mechanisms of Symptoms of Multiple Myeloma and Its Therapy
|
1P01CA124787-01A2
|
$2,128,821
|
$212,882
|
CLEELAND, CHARLES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Enhancing the efficacy of CD19-specific cord blood-derived T Cells
|
5R01CA120956-02
|
$292,600
|
$146,300
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-02
|
$292,600
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Imaging Infused CD19 Specific T Cells in the Tumor
|
5R21CA129390-02
|
$154,000
|
$154,000
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
In vivo targeted DC vaccine to activate anti-tumor CTL
|
5R01CA112065-04
|
$329,612
|
$329,612
|
CUI, YAN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
1P30CA134274-01
|
$1,463,613
|
$43,908
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S1
|
$125,023
|
$5,001
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S2
|
$193,710
|
$7,748
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-10
|
$2,780,246
|
$111,210
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Poor competition in hematopoietic stem/ progenitor pools favors tumorigenesis
|
5R01CA109657-04
|
$214,532
|
$21,453
|
DEGREGORI, JAMES
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular & Genetic Determinants of Outcome in Breast Cancer
|
5R01CA104581-05
|
$296,181
|
$148,091
|
DEMICHELE, ANGELA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
3R01CA077544-10S1
|
$110,460
|
$110,460
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Peptide Vaccine To Prevent CMV Disease After HSCT
|
5R01CA077544-10
|
$468,767
|
$468,767
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
Total relevant funding to Organ Transplantation Research for this search: $65,435,562
|